A MULTI-CENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED MULTIPLE ASCENDING DOSE STUDY TO EVALUATE THE SAFETY AND TOLERABILITY OF QRL-201 IN AMYOTROPHIC LATERAL SCLEROSIS

Status

Active, not recruiting

Phases

Phase 1

Study type

Interventional

Source

EU CTIS

Registry ID

CTIS2022-500758-41-00

Acronym

QRL-201-01

Enrollment

Registered

2023-05-22

Start date

2023-08-15

Completion date

Unknown

Last updated

2025-12-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Amyotrophic lateral sclerosis

None listed

Sex/Gender

All

Age

18 Years to No maximum

Belgium, Germany, Ireland, Netherlands

None listed

Source: EU CTIS · Data processed: Feb 4, 2026